News
X-ZELL facing three start-up competition finals in one week
Singapore, November 2020 – Singapore start-up X-ZELL has been nominated for the finals of three high-profile start-up competitions and accelerator programs, all taking place within the same week from 11-18 Nov 2020. World’s Most Innovative Health Tech Start-up...
X-ZELL closes oversubscribed Seed+ round
Singapore, October 2020 – Singapore start-up X-ZELL has closed an oversubscribed Seed+ round led by German industrial service group, Deutsche Industrieanlagen (DIAG). Ranked among the world's most innovative health technology start-ups[1], X-ZELL specialises in the...
X-ZELL selected for prestigious MedTech Innovator Accelerator program
Singapore, July 2020 – X-ZELL is one of 20 start-ups to be selected for MedTech Innovator’s 2020 Asia Pacific Accelerator program. Founded in 2013, MedTech Innovator is a Los Angeles-based non-profit organisation specialising in medical technology and digital health,...
Next generation Cryoimmunostaining™ Suite revealed
Singapore, June 2020 – 18 months after premiering at the 2019 Medlab Asia exhibition in Singapore, X-ZELL’s game-changing Cryoimmunostaining™ Suite is about to receive a facelift. According to X-ZELL’s Head of Medical Devices, Bart Van der Voort, the next generation...
X-ZELL part of Galen Growth’s 2020 HealthTech Cohort
Singapore, May 2020 – X-ZELL is one of 23 start-ups selected to be part of Galen Growth’s inaugural HealthTech Cohort, an acceleration and networking initiative designed to champion healthcare innovation from across Asia. According to Julien de Salaberry, CEO &...
Essex Bio-Technology joins X-ZELL Seed+ Investment Round
Singapore/Hong Kong, April 2020 – Rare cell detection specialist X-ZELL has entered into an investment agreement with Essex Bio-Investment, a wholly owned subsidiary of Essex Bio-Technology Ltd (“EssexBio”). Ranked amongst Asia’s 50 most innovative health technology...
X-ZELL featured in German life science magazine Laborjournal
Freiburg, April 2020 – X-ZELL has been featured in the April edition of Laborjournal, one of Germany’s leading life science publications. The extensive company profile, penned by science journalist Dr Sigrid März, outlines X-ZELL’s rapid ascent from a small Bangkok...
Interview: Krebs im Blut
Due to the overwhelming response to X-ZELL’s recent Live Sessions tour around Germany, we sat down with X-ZELL Founder & CEO, Dr Sebastian Bhakdi, to interview him in his native language. Singapur, Februar 2020 – Der deutsche Arzt Dr. Sebastian Bhakdi (44) ist...
X-ZELL Cryoimmunostaining™ technology touring Europe
Brussels, February 2020 – Following the official European launch of X-ZELL’s Cryoimmunostaining™ Suite in November 2019, the Singapore start-up will be holding a series of Live Sessions in 2020 in order to introduce the new technology to some of the leading minds in...
X-ZELL selected as Finalist for 2020 Hello Tomorrow Global Challenge
Singapore, January 2020 – Singapore med tech start-up, X-ZELL, has been nominated as a Global Finalist for the 2020 Hello Tomorrow Challenge. Considered one of the world’s leading deep tech start-up competitions, the Challenge was created to celebrate the “best and...
X-ZELL
© 2023 X-ZELL INC
Find Us